EMA Authorised: Comtan (entacapone) — Orion Corporation

View source ↗

Summary

European Medicines Agency authorised Comtan (entacapone) for Parkinson disease with Orion Corporation as the marketing authorisation holder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Comtan (entacapone)

Snippet

Status: Authorised. Therapeutic area: Parkinson Disease. MAH: Orion Corporation. Decision date: 05/09/2024